Study reveals potential targets to improve the treatment of myeloma

A ground-breaking study by researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS) has revealed crucial insights into the role of the histone methyltransferase NSD2 and its epigenetic target PKCα in causing t(4;14) translocated multiple myeloma (MM), a high-risk subtype of blood cancer, to be more aggressive and resistant to treatment.

Long-term exposure to particulates from wildfire smoke linked to dementia risk, new study finds

Smoke permeates everything and impacts everyone. The visible stew of carbon and particulates typically from emission sources travels in the air, shrouds buildings, suffocates birds,

August 14, 2023

Reducing physical activity disparities between genders could save billions

Eliminating current physical activity disparities between male and female youth in the United States could save around $780 million for each new cohort of six-to-17-year-olds,

November 27, 2024

Recalled Pacemakers; FDA Rejects Full Andexxa Approval; Ticagrelor Back in Hot Seat

The FDA is alerting clinicians to a recall of Boston Scientific’s Accolade pacemakers, which have an increased risk of permanently entering “safety mode,” possibly requiring

December 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.